«Previous Article|Table of Contents|Next Article»

Journal Of Modern Oncology[ISSN:1672-4992/CN:61-1415/R]

Issue:

2020 04

Page:

676-678

Research Field:

Publishing date:

Info

Title:

Progress on neoadjuvant therapy in rectal cancer

Author(s):

Wang Zhong¹; Yuan Juan²

1.Department of Oncology;2.Department of Obstetrics and Gynecology£¬Xiangtan Central Hospital£¬Hunan Xiangtan 411100£¬China.

Keywords:

rectal cancer; local advanced stage; neoadjuvant therapy

PACS:

R735.3+7

DOI:

10.3969/j.issn.1672-4992.2020.04.036

Abstract:

Neoadjuvant therapy has become the standard treatment for local advanced middle and low rectal cancer in recent years.Long course concurrent chemoradiotherapy and short course radiotherapy are commonly used.Total neoadjuvant therapy is also feasible neoadjuvant strategy.The relavent clinical research on watch-and-wait is also proceeding after its obtain clinical complete response.This article reviewed the current status and research progress on neoadjuvant therapy in rectal cancer.

References:

£Û1£ÝZHENG Rongshou,SUN Kexin,ZHANG Siwei,et al.Report of cancer epidemiology in China,2015£ÛJ£Ý.Chin J Oncol,2019,41(1):19-28.£ÛÖ£ÈÙÊÙ,Ëï¿ÉÐÀ,ÕÅ˼ά,µÈ.2015ÄêÖйú¶ñÐÔÖ×ÁöÁ÷ÐÐÇé¿ö·ÖÎö£ÛJ£Ý.ÖлªÖ×ÁöÔÓÖ¾,2019,41(1):19-28.£Ý
£Û2£ÝSauer R,Liersch T,Merkel S,et al.Preoperative versus postoperative chemoradiotherapy for locally advanced rectal cancer:Results of the German CAO/ARO/AIO-94 randomized phase III trial after a median follow-up of 11 years£ÛJ£Ý.J Clin Oncol,2012(30):1926-1933.
£Û3£ÝChapman BC,Goodman K,Hosokawa P,et al.Improved survival in rectal cancer patients who are treated with long-course versus short-course neoadjuvant radiotherapy:A propensity-matched analysis of the NCDB£ÛJ£Ý.J Surg Oncol,2019,119(4):518-531.
£Û4£ÝHofheinz RD,Wenz F,Post S,et al.Chemoradiotherapy with capecitabine versus fluorouracil for locally advanced rectal cancer:A randomised,multicentre,non-inferiority,phase 3 trial£ÛJ£Ý.Lancet Oncol,2012(13):579-588.
£Û5£ÝValentini V,Gambacorta MA,Cellini F,et al.The INTERACT Trial:Long-term results of a randomised trial on preoperative capecitabine-based radiochemotherapy intensified by concomitant boost or oxaliplatin,for cT2 (distal)-cT3 rectal cancer£ÛJ£Ý.Radiother Oncol,2019(134):110-118.
£Û6£ÝRombouts AJM,Hugen N,Elferink MAG,et al.Treatment interval between neoadjuvant chemoradiotherapy and surgery in rectal cancer patients:A population-based study£ÛJ£Ý.Ann Surg Oncol,2016,23(11):3593-3601.
£Û7£ÝJ¢|ger T,Neureiter D,Urbas R,et al.Applicability of American Joint Committee on Cancer and College of American Pathologists Regression Grading System in Rectal Cancer£ÛJ£Ý.Dis Colon Rectum,2017,60(8):815-826.
£Û8£ÝRaldow AC,Chen AB,Russell M,et al.Cost-effectiveness of short-course radiation therapy vs long-course chemoradiation for locally advanced rectal cancer£ÛJ£Ý.JAMA Netw Open,2019,2(4):e192249.
£Û9£ÝMa B,Gao P,Song Y,et al.Short-course radiotherapy in neoadjuvant treatment for rectal cancer:A systematic review and Meta-analysis£ÛJ£Ý.Clin Colorectal Cancer,2018,17(4):320-330.
£Û10£ÝWang X,Zheng B,Lu X,et al.Preoperative short-course radiotherapy and long-course radiochemotherapy for locally advanced rectal cancer:Meta-analysis with trial sequential analysis of long-term survival data£ÛJ£Ý.PLoS One,2018,13(7):e0200142.
£Û11£ÝNgan SY,Burmeister B,Fisher RJ,et al.Randomized trial of short-course radiotherapy versus long-course chemoradiation comparing rates of local recurrence in patients with T3 rectal cancer:Trans-Tasman Radiation Oncology Group trial 01.04£ÛJ£Ý.J Clin Oncol,2012£¨30£©:3827-3833.
£Û12£ÝWu H,Fang C,Huang L,et al.Short-course radiotherapy with immediate or delayed surgery in rectal cancer:A Meta-analysis£ÛJ£Ý.Int J Surg,2018£¨56£©:195-202.
£Û13£ÝAghili M,Sotoudeh S,Ghalehtaki R,et al.Preoperative short course radiotherapy with concurrent and consolidation chemotherapies followed by delayed surgery in locally advanced rectal cancer:Preliminary results£ÛJ£Ý.Radiat Oncol J,2018,36(1):17-24.
£Û14£ÝSk¨®ra T,Nowak-Sadzikowska J,Martyn¨®w D,et al.Preoperative short-course radiotherapy in rectal cancer patients:Results and prognostic factors£ÛJ£Ý.J Radiat Oncol,2018,7(1):77-84.
£Û15£ÝGollins S,West N,Sebag-Montefiore D,et al.A prospective phase II study of pre-operative chemotherapy then short-course radiotherapy for high risk rectal cancer:COPERNICUS£ÛJ£Ý.Br J Cancer,2018,119(6):697-706.
£Û16£ÝSmith CA,Kachnic LA.Evolving treatment paradigm in the treatment of locally advanced rectal cancer£ÛJ£Ý.J Natl Compr Canc Netw£¬2018£¬16(7):909-915.
£Û17£ÝGoodman KA.Total neoadjuvant therapy for rectal cancer£ÛJ£Ý.Cancer Radiother,2018,22(5):459-465.
£Û18£Ývan Zoggel DMGI,Bosman SJ,Kusters M,et al.Preliminary results of a cohort study of induction chemotherapy-based treatment for locally recurrent rectal cancer£ÛJ£Ý.Br J Surg,2018,105(4):447-452.
£Û19£ÝLudmir EB,Palta M,Willett CG,et al.Total neoadjuvant therapy for rectal cancer:An emerging option£ÛJ£Ý.Cancer,2017,123(9):1497-1506.
£Û20£ÝGollub MJ,Blazic I,Bates DDB,et al.Pelvic MRI after induction chemotherapy and before long-course chemoradiation therapy for rectal cancer:What are the imaging findings£ÛJ£Ý? Eur Radiol£¬2019£¬29(4):1733-1742.
£Û21£ÝCercek A,Roxburgh CSD,Strombom P,et al.Adoption of total neoadjuvant therapy for locally advanced rectal cancer£ÛJ£Ý.JAMA Oncol,2018,4(6):e180071.doi:10.1001/jamaoncol.2018.0071.
£Û22£ÝWright ME,Beaty JS,Thorson AG,et al.Cost-effectiveness analysis of total neoadjuvant therapy followed by radical resection versus conventional therapy for locally advanced rectal cancer£ÛJ£Ý.Dis Colon Rectum£¬2019£¬62(5):568-578.
£Û23£ÝHupkens BJP,Martens MH,Stoot JH,et al.Quality of life in rectal cancer patients after chemoradiation:Watch-and-wait policy versus standard resection-A matched-controlled study£ÛJ£Ý.Dis Colon Rectum,2017,60(10):1032-1040.
£Û24£ÝSmith JJ,Strombom P,Chow OS,et al.Assessment of a watch-and-wait strategy for rectal cancer in patients with a complete response after neoadjuvant therapy£ÛJ£Ý.JAMA Oncol,2019,5(4):e185896.
£Û25£ÝMoreno CC,Sullivan PS,Mittal PK.Rectal MRI for cancer staging and surveillance£ÛJ£Ý.Gastroenterol Clin North Am,2018,47(3):537-552.
£Û26£ÝStrode M,Shah R,Boland PM,et al.Nonoperative management after neoadjuvant therapy for rectal cancer:A single institution experience over 5 years£ÛJ£Ý.Surg Oncol£¬2019(28):116-120.
£Û27£ÝDattani M,Heald RJ,Goussous G,et al.Oncological and survival outcomes in watch and wait patients with a clinical complete response after neoadjuvant chemoradiotherapy for rectal cancer:A systematic review and pooled analysis£ÛJ£Ý.Ann Surg,2018,268(6):955-967.
£Û28£Ývan der Valk MJM,Hilling DE,Bastiaannet E,et al.IWWD Consortium.Long-term outcomes of clinical complete responders after neoadjuvant treatment for rectal cancer in the International Watch & Wait Database (IWWD):An international multicentre registry study£ÛJ£Ý.Lancet,2018,391(10139):2537-2545.
£Û29£ÝBernier L,Balyasnikova S,Tait D,et al.Watch-and-wait as a therapeutic strategy in rectal cancer£ÛJ£Ý.Curr Colorectal Cancer Rep,2018,14(2):37-55.
£Û30£ÝOn J,Aly EH.'Watch and wait' in rectal cancer:Summary of the current evidence£ÛJ£Ý.Int J Colorectal Dis,2018,33(9):1159-1168.

Memo

Memo:

Ïæ̶ÊÐҽѧ¿ÆÑÐÏîÄ¿£Û±àºÅ£ºÌ¶ÎÀº¯£¨2016£©31ºÅ8£Ý

Common functions

Last Update: 2019-12-26